

<!DOCTYPE html>

<html lang="uz-Cyrl-UZ">
<head>
   <!-- Global site tag (gtag.js) - Google Analytics -->
   <script async src="https://www.googletagmanager.com/gtag/js?id=UA-2682682-1"></script>
   <script>
      window.dataLayer = window.dataLayer || [];
      function gtag() { dataLayer.push(arguments); }
      gtag('js', new Date());
      gtag('config', 'UA-2682682-1');
   </script>
<title>

</title><meta charset="UTF-8" /><meta http-equiv="content-type" content="text/html; charset=UTF-8" /><meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=0.3, maximum-scale=3.0" /><link href="/css/mactform.css" rel="stylesheet" type="text/css" />

    <style type="text/css">
        /*.contents-caption DIV {
            float: right;
        }*/

        /*.mobilnav TD {
            height: 32px;
        }*/

        /*.mobilnav {
            border: 0px;
            padding: 0;
            background: url('/image/h-menu.gif') repeat-x scroll left top transparent;
        }*/

        body {
            margin: 0;
        }

        td {
            min-height: 22px;
        }

        /*#userComments {
            position: fixed;
            top: 0;
            left: 200px;
            width: 279px;
            height: 18px;
            background-color: Black;
            color: White;
            z-index: 2000;
            padding: 3px;
            display: none;
        }*/

        /*#fancybox_div {
            display: none;
        }*/

        /*#divContextRasporka {
            width: 270px;
        }*/

        /*#tddivContext {
            background-color: White;
        }*/

        /*#backButton {
            color: White;
            font-weight: bold;
            text-decoration: none;
        }*/

        /*#divCont {
            padding-top: 35px;
        }*/

        /*.main_menu ul .checkboxArea, .main_menu ul .checkboxAreaChecked {
            padding-top: 12px;
        }*/

        /*#item3 > ul > li {
            white-space: nowrap;
        }*/

        /*header > nav > ul > li > a {
            font-family: Arial;
            font-size: 11px;
        }*/

        /*#actContent a {
            font-size: 14px;
            font-family: Arial;
        }*/

        /*#selected_div {
            height: 250px;
            overflow: auto;
            padding: 6px 1px 1px 9px;
        }*/

        /*.enter_submit {
            background: url("/images/bg/search_button_bg.jpg") repeat-x scroll 0 0 transparent;
            border: 1px solid #7190EE;
            border-radius: 6px 6px 6px 6px;
            float: right;
            margin-right: 2px;
            cursor: pointer;
        }*/

        /*.enter_submit > div {
                background: url("/images/arrow/button_uzor4_left.png") no-repeat scroll 4px 7px transparent;
                float: left;
                width: 100%;
                cursor: pointer;
            }*/

        /*.enter_submit input[type="button"] {
                background: url("/images/arrow/button_uzor4_right.png") no-repeat scroll right 7px transparent;
                border: medium none;
                border-radius: 6px 6px 6px 6px;
                color: #FFFFFF;
                float: left;
                font-size: 12px;
                font-weight: bold;
                height: 21px;
                margin-left: 22px;
                margin-right: 4px;
                padding: 0 22px 3px 0;
                cursor: pointer;
            }*/

        .show_context {
            background-color: #FFFF00;
            color: inherit;
        }
    </style>
    <style id="tree_style" type="text/css">
        #divAct a, #divAct DIV, #divAct font, div#theDefCssID table td, th {
            font-size: 12pt;
        }
    </style>

    <script type="text/javascript" charset="utf-8">
        //window.onbeforeunload = function () {
        //    //document.getElementById("main_container").innerHTML = "";
        //    //window.body.style.background = "red";  //css("background", "red");
        //    //window.scrollTo(0, 0);
        //}

        window.onload = function () {
            setTimeout(function () { scrolPage(); }, 100);
        }

        function scrolPage() {
            var hash = location.hash.toString();
            if (hash.length > 2) {
                var elem = document.getElementById(location.hash.toString().substring(1));
                if (elem === null || elem === undefined) {
                    document.body.scrollTop = document.documentElement.scrollTop = 0;
                }
                else {
                    document.body.scrollTop = document.documentElement.scrollTop = elem.offsetTop - 10;
                }
            }
            else {
                document.body.scrollTop = document.documentElement.scrollTop = 0;
            }
        }
    </script>
</head>
<body>
    
    <a href="#DynContent" id="DynContentBtn"></a>
    <div style="display: none;">
        <div id="DynContent" style="width: 350px;">
            <table>
                <tr>
                    <td><span id="dynText"></span></td>
                </tr>
            </table>
        </div>
    </div>
    <div id="headcont">
        
        <header style="z-index: 2000;" id="headermenu">
            <div class='logo' style="padding: 0px 0px 0px 8px">
                <a href='/'><span></span></a>
            </div>
        </header>
        
    </div>
    <div id='main_container'>
        
        <section class='main_text'>
            <table style="width: 100%; font-family: Arial; font-size: 14px; font-weight: bold;">
                <tr>
                    <td style="width: 50%">
                        
                            <div class="act_warning">
                                Hujjat kuchini yo‘qotgan " " 08.06.2019
                            </div>
                        
                        
                        
                    </td>
                    <td style="width: 50%; text-align: right">
                        
                        
                    </td>
                </tr>
            </table>
            <div id="divAct" style="margin: 0px; padding: 0px 5px 0px 5px; background: white;">
                
                <div id="divCont" style="background:#ffffff;border:none;margin:auto;"><div class="INDEXES_ON_REF" style="display:none"><label id="s5987"></label><div name="onLBC-2995684" id="onLBC-2995684">[<b>OKOZ:</b><div id="LBC7382"><span class="iorRN">1.</span><span class="iorVal">14.00.00.00 Sogʻliqni saqlash. Jismoniy tarbiya. Sport. Turizm / 14.01.00.00 Sogʻliqni saqlash / 14.01.04.00 Sogʻliqni saqlash muassasalarini, aholini medikamentlar, dori-darmon vositalari va tibbiy buyumlar bilan taʼminlash. Dorixona]</span></div></div></div><div class="INDEXES_ON_REF" style="display:none"><label id="s5988"></label><div name="onLS-2995684" id="onLS-2995684">[<b>TSZ:</b><div id="LS3700"><span class="iorRN">1.</span><span class="iorVal">Ijtimoiy-madaniy masalalar / Sogʻliqni saqlash. Sanitariyaga oid qonun hujjatlari]</span></div></div></div><div class="ACCEPTING_BODY"><div name="-2995702" id="-2995702">Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirining</div></div><div class="ACT_FORM"><div name="-2995703" id="-2995703">buyrugʻi</div></div><div class="ACT_TITLE"><div name="-2995704" id="-2995704">Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari roʻyxatini tasdiqlash toʻgʻrisida</div></div><div class="DEPARTMENTAL"><div name="-2995705" id="-2995705">[Oʻzbekiston Respublikasi Adliya vazirligi tomonidan 2016-yil 1-iyulda roʻyxatdan oʻtkazildi, roʻyxat raqami 2805]</div></div><div class="BY_DEFAULT"><div name="-2995706" id="-2995706"></div></div><div class="COMMENT"><label id="s527"></label><div class="COMMENTLEXUZ"><img src="/image/favicon.gif" /> LexUZ sharhi</div><div name="-4369741" id="-4369741">Mazkur buyruq Oʻzbekiston Respublikasi sogʻliqni saqlash vazirining 2019-yil 22-maydagi 76-sonli “Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari roʻyxatini tasdiqlash toʻgʻrisida”gi <a href="/acts/-4367869?ONDATE=08.06.2019 00#-4368094">buyrugʻiga </a>(roʻyxat raqami 3164, 07.06.2019-y.) asosan oʻz kuchini yoʻqotgan.</div></div><div class="ACT_TEXT"><div name="-2995707" id="-2995707">Oʻzbekiston Respublikasining “Dori vositalari va farmatsevtika faoliyati toʻgʻrisida”gi <a href="/acts/-2856464">Qonuniga</a> muvofiq buyuraman:</div></div><div class="ACT_TEXT"><div name="-2995708" id="-2995708">1. Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari roʻyxati <a href="/acts/-2995684#-2995715">ilovaga</a> muvofiq tasdiqlansin.</div></div><div class="ACT_TEXT"><div name="-2995709" id="-2995709">2. Mazkur buyruq rasmiy eʼlon qilingan kundan eʼtiboran uch oy oʻtgach kuchga kiradi.</div></div><div class="SIGNATURE"><div name="-2995710" id="-2995710">Vazir A. ALIMOV</div></div><div class="ACT_ESSENTIAL_ELEMENTS"><div name="-2995711" id="-2995711">Toshkent sh.,</div></div><div class="ACT_ESSENTIAL_ELEMENTS"><div name="-2995712" id="-2995712">2016-yil 23-iyun,</div></div><div class="ACT_ESSENTIAL_ELEMENTS_NUM"><div name="-2995713" id="-2995713">57-son</div></div><div class="BY_DEFAULT"><div name="-2995714" id="-2995714"></div></div><div class="APPL_BANNER_LANDSCAPE_TITLE"><div name="-2995715" id="-2995715">Oʻzbekiston Respublikasi sogʻliqni saqlash vazirining 2016-yil 23-iyundagi 57-sonli <a href="/acts/-2995684">buyrugʻiga<br /></a>ILOVA</div></div><div class="ACT_TITLE_APPL"><div name="-2995716" id="-2995716">Kam uchraydigan kasalliklarni davolash uchun moʻljallangan Orfan dori vositalari</div></div><div class="ACT_FORM"><div name="-2995717" id="-2995717"><strong>ROʻYXATI</strong></div></div><div class="BY_DEFAULT"><div name="-2995718" id="-2995718"></div></div><div class="BY_DEFAULT"><div name="-2995722" id="-2995722"><table style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; BORDER-COLLAPSE: collapse; BACKGROUND: white; BORDER-TOP: medium none; BORDER-RIGHT: medium none" border="1" cellspacing="0" cellpadding="0" width="100%">
<tbody>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><b><span style="COLOR: black">T/r</span></b></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><b><span style="COLOR: black">Dori vositasining xalqaro patentlanmagan nomi</span></b></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><b><span style="COLOR: black">Kasalliklarning xalqaro tasnifi boʻyicha kasallik guruhi</span></b></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><b><span style="COLOR: black">Kasallikning nomi (uning sinonimi)</span></b></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><b><span style="COLOR: black">Kasalliklarning xalqaro tasnifi <br />(KXT-10) boʻyicha </span></b><b><span style="COLOR: black">kodi</span></b></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>1.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Dapson </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Lepra</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Lepra (Ganzen kasalligi)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">A-30</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>2.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Klofazimin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>3.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Glyukantim </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="5" width="24%">
<p align="center"><span style="COLOR: black">Leyshmanioz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="5" width="23%">
<p align="center"><span style="COLOR: black">Teri leyshmaniozi, visseral leyshmanioz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="5" width="22%">
<p align="center"><span style="COLOR: black">B-55</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>4.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Metatsiklin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>5.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Rondomitsin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>6.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Doksilan</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>7.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Xingamin </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="5%">
<p align="center"><span>8.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p><span style="COLOR: black">Kafast</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Angiokeratoma</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Fabri kasalligi (angiokeratoma)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D-18</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Mezenximoz Legera</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Danlos sindromi<br />(Mezenximoz Legera)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">L-94</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>9.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Kuriozin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Pensigoid</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Bullyoz epidermoliz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">Q-81</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>10.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Argosulfan</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>11.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Paraaminobenzoy kislota</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Lentiginoz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Peyts-Djigers-Turen sindromi (periorifitsial lentiginoz)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">R-19</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>12.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tigazon</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Lepra</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Lepra (Ganzen kasalligi)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">A-30</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>13.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Penitsilamin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Vilsona-Konavalova sindromi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Vilsona-Konavalova sindromi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">E 83.0</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>14.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Gansiklovir </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Sitomegalovirusli infeksiya</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Sitomegalovirusli infeksiya</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">V 25, V 45</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>15.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Etravirin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="27" width="24%">
<p align="center"><span style="COLOR: black">Odamning immunitet tanqisligi virusi (OIV) tomonidan chaqirilgan kasallik, Odamning immunitet tanqisligi virusi (OIV) rezistent shtamlari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="27" width="23%">
<p align="center"><span style="COLOR: black">Odamning immunitet tanqisligi virusi (OIV) tomonidan chaqirilgan kasallik, Odamning immunitet tanqisligi virusi (OIV) rezistent shtamlari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="27" width="22%">

<p align="center"><span style="COLOR: black">B 20-B 24</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>16.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Raltegravir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>17.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Dalutegravir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>18.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Darunovir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>19.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Atazanavir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>20.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Zidovudin </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>21.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Lamivudin </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>22.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Abakavir </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>23.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tenofovir </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>24.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Emtritsitabin </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>25.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Nevirapin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>26.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Rilpivirin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>27.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Efavirenz</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>28.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Ritonavir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>29.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Elvitegravir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>30.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Maravirok</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>31.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Zidovudin + Lamivudin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>32.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Abakavir + Lamivudin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>33.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Emtritsitabin + Tenofovir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>34.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Lamivudin + Tenofovir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>35.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Efavirenz + Emtritsitabin + Tenofovir </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>36.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Efavirenz + Lamivudin + Tenofovir </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>37.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Rilpivirin + Emtritsitabin + Tenofovir </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>38.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Lopinavir + Ritonavir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>39.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Darunavir + Kobisistat</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>40.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Atazanavir + Kobisistat</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>41.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Elvitegravir + Kobisistat + Emtritsitabin + Tenofovir</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>42.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Koartem</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Bezgak</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Bezgak</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">V 52</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>43.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Takrolimus</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Buyrak koʻchirib oʻtkazilgandan keyingi holat</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">-</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>44.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Primaxin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="10" width="24%">
<p align="center"><span style="COLOR: black">Pl. Malariae, </span></p>
<p align="center"><span style="COLOR: black">Pl. Falciparum</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="10" width="23%">
<p align="center"><span style="COLOR: black">Bezgak</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="10" width="22%">
<p align="center"><span style="COLOR: black">V 53</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>45.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Xinidin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>46.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Xloroxin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>47.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Xinin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>48.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Atremetr</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>49.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Artesunat</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>50.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Lariam</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>51.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Fansidar</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>52.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Ambizom</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>53.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Pentostam</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>54.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Liposomalli Amfoteritsin V </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Zamburugʻ </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Zamburugʻ </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">V 55</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>55.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Antilimfotsitar globulin A</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Aplastik anemiya</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Aplastik anemiya</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D 61</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>56.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Paromomitsin sulfat</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Leyshmanioz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Leyshmanioz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">B 55</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>57.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Interferon beta</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Bolalarda uchraydigan burun-halqum xavfli oʻsmalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Burun-halqum xavfli oʻsmasi (nazofarengial karsinoma)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">S 11</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>58.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Melfalan</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Bolalarda uchraydigan koʻz va uning yondosh apparati, toʻr parda xavfli oʻsmalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Toʻr parda xavfli oʻsmasi (retinoblastoma)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">C 69.2</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>59.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Siklofosfamid Mesna</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Buyrak usti bezi xavfli oʻsmasi </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Buyrak usti bezi poʻstloq qismi xavfli oʻsmasi </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">C 74.0</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>60.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Mitotan</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>61.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Lomustin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Bosh miya xavfli oʻsmalari, xavfli limfomalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Bosh miya xavfli oʻsmalari, xavfli limfomalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">S 71</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>62.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Nimustin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>63.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Prokarbazin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Limfoproliferativ kasalliklar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Xodjkin limfomasi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">S 80</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>64.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Adsetris</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>65.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Syetuksimab </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Bosh-boʻyin xavfli oʻsmalari </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Bosh-boʻyin <br />(ogʻiz, burun, halqum boʻshliqlari) xavfli oʻsmalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">C 00-C 14</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>66.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Prospidiya xlorid</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Sarkoma Kaposhi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Sarkoma Kaposhi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">S 46</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>67.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Alitretinoin </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>68.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Azatsitidin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="9" width="24%">
<p align="center"><span style="COLOR: black">Miyeloid, qon yaratuvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari, Limfoid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari, Limfoid leykozi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="9" width="23%">
<p align="center"><span style="COLOR: black">Limfoid leykozi (limfoleykoz), Miyelom kasalligi, surunkali miyeloleykoz, </span></p>
<p align="center"><span style="COLOR: black">oʻtkir leykozlar, </span></p>
<p align="center"><span style="COLOR: black">xoj sochlik leykoz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="9" width="22%">
<p align="center"><span style="COLOR: black">C 88, S 90, C 91. S 92, S 92.1,</span></p>
<p align="center"><span style="COLOR: black">S 92.4, S 93, C 94, S 95, S 96,S 91.4</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>69.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Asparaginaza</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>70.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Bendamustin </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>71.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Bortezomib</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>72.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Idarubitsin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>73.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Imatinib</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>74.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Kladribin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>75.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Mofetila mikofenolat</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>76.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">PEGAsparaginaza</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>77.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tretinoin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Limfoid leykozi (limfoleykoz), qon ishlab chiqaruvchi <br />va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Oʻtkir limfoblast leykozi, </span></p>
<p align="center"><span style="COLOR: black">oʻtkir leykozlar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">S 92.4</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>78.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Deferoksamin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Gemolitik kam qonliklar, Qon va qon yaratuvchi organlar kasalliklari va immun mexanizmini jalb etuvchi ayrim buzilishlar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Alfa-talassemiya, beta-talassemiya, delta-beta-talassemiya, Aplastik kamqonliklar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">D 56, D 61</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>79.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Deferaziroks</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>80.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Antitimotsitar globulin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="24%">
<p align="center"><span style="COLOR: black">Qon va qon yaratuvchi organlar kasalliklari va immun mexanizmini jalb etuvchi ayrim buzilishlar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="23%">
<p align="center"><span style="COLOR: black">Aplastik kamqonliklar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="22%">
<p align="center"><span style="COLOR: black">D 61</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>81.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Siklosporin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>82.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Antitimotsitar immunoglobulin (ATG)</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>83.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Oktanat</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="6" width="24%">
<p align="center"><span style="COLOR: black">Gemofiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="6" width="23%">
<p align="center"><span style="COLOR: black">Gemofiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="6" width="22%">
<p align="center"><span style="COLOR: black">D 66, <br />D 67, D 68,0</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>84.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Immunat</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>85.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Beriate</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>86.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Gemoktin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>87.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Oktanayn</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>88.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Immunin </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>89.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tirozinkinaza ingibitorlari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="6" width="24%">
<p align="center"><span style="COLOR: black">Miyeloid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="6" width="23%">
<p align="center"><span style="COLOR: black">Surunkali miyeloleykoz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="6" width="22%">
<p align="center"><span style="COLOR: black">C 92.1</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>90.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Interferon alfa</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>91.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tasigna </span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>92.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Spraysel</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>93.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Vilate</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>94.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Odam leykotsitar interferoni</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>95.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Metilprednizolon</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Qon va qon ishlab chiqaruvchi organlar kasalliklari va immun mexanizmini jalb etuvchi ayrim buzilishlar </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Idiopatik trombotsitopenik purpura </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D 69.3</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>96.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Imiglyutseraza</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">I tipdagi Goshe kasalligi </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D 80, E 75.2</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>97.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Lenalidomid</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Miyeloid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Miyelodisplastik sindrom</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D 46</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>98.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Mitoksantron</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="24%">
<p align="center"><span style="COLOR: black">Limfoid, qon ishlab chiqaruvchi va ularga yaqin boʻlgan toʻqimalar xavfli oʻsmalari</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="23%">
<p align="center"><span style="COLOR: black">Oʻtkir leykozlar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="22%">
<p align="center"><span style="COLOR: black">S 88.0-</span></p>
<p align="center"><span style="COLOR: black">S 92.4-92.0</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>99.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Azotsidin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>100.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Palivizumab</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>101.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Salofalk</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Kron kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Kron kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">K 50</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>102.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Triyentin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Vilson-Konovalov kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Vilson-Konovalov kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">E 83.0</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>103.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tetratiomolibdat</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Vilson kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Vilson kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">E 83.0</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>104.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Mitoksantrin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>105.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Bromitob</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="24%">
<p align="center"><span style="COLOR: black">Mukovissidoz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="23%">
<p align="center"><span style="COLOR: black">Mukovissidoz </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="22%">
<p align="center"><span style="COLOR: black">E 84</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>106.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tobidornazar alfa</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>107.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Dornaza-alfa</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>108.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Tobramitsin (ingalatsion shakl)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Modda almashinuvi buzilishi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Fibroz kistozining majmuaviy shakli (mukovissidoz)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">G 35</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="5%">
<p align="center"><span>109.</span></p>
<p align="center"></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p><span>Natalizumab</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span>Tarqoq skleroz, Bolalarda uchraydigan tarqoq skleroz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span>Tarqoq skleroz, Sil sklerozining kompleksi </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span>G 35</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span>(SEGA)</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>110.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Bozentan</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Birlamchi oʻpka gipertenziyasi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Idiopatik oʻpka arterial gipotenziyasi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">I 27.0</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>111.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Odam normal immunoglobulini</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Purpura va boshqa gemorragik holatlar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Idiopatik trombotsitopenik purpura </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D 69</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>112.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Azatioprin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Toʻqimalar birlashishining tizimli zararlanishi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Vegenera Granulomatozining mikroskopik poliangiti</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">G 35</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>113.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Metotreksat</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>114.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Ibandron kislotasi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Yakunlanmagan osteogenez</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Yakunlanmagan osteogenez</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">S 88-S 90</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>115.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Siklosporin A</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Alport sindromi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Alport sindromi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">Q 87.8</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>116.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Trenaksan</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Gemorragik sindromlar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Gemafiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D 66, D 67, D 68</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>117.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Aminoglutyetimid</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="4" width="24%">
<p align="center"><span>Gipofiz giperfunksiyasi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Kushing sindromi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="4" width="22%">
<p align="center"><span>E 22</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>118.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Lanrenotid</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="23%">
<p align="center"><span>Akromegaliya Kushing sindromi</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>119.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Kabergolin</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>120.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Parlodel</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>121.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Rastan</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="24%">
<p align="center"><span style="COLOR: black">Boshqa endokrin kasalliklar </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="3" width="23%">
<p align="center"><span style="COLOR: black">Pradera-Villi sindromi,</span></p>
<p align="center"><span style="COLOR: black">Nunan Shereshevskiy-Ternera sindromi </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">Q 87.1</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>122.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Norditropin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">Q 96</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>123.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Kortizon</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">-</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>124.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Glatiamer</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Tarqoq skleroz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Tarqoq skleroz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">G 35</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>125.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">VIII va IX qon koagulya­tsiyasi omili</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Gemofiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Gemofiliya A, V, Villebrand kasalligi</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">D 66, D 67, D 68</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>126.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Sitarabin</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Mileloid leykoz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Mileloid leykoz</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">S 91-S 92</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>127.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Gidrokortizon</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="24%">
<p align="center"><span style="COLOR: black">Adrenogenital buzilishlar </span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="23%">
<p align="center"><span style="COLOR: black">Fermentlar tanqisligi bilan bogʻliq boʻlgan tugʻma adrenogenital buzilishlar</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" rowspan="2" width="22%">
<p align="center"><span style="COLOR: black">E 25.0,</span></p>
<p align="center"><span style="COLOR: black">E 27.1</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>128.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Kortineff</span></p></td></tr>
<tr>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: windowtext 1pt solid; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="5%">
<p align="center"><span>129.</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p><span style="COLOR: black">Kalsitriol</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="24%">
<p align="center"><span style="COLOR: black">Surunkali buyrak yetishmovchiligi, Vitamin D rezistent raxit (fosfat diabet, buyrak raxiti)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="23%">
<p align="center"><span style="COLOR: black">Surunkali buyrak yetishmovchiligi, Vitamin D rezistent raxit (fosfat diabet, buyrak raxiti)</span></p></td>
<td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: #-ece9d8; PADDING-BOTTOM: 0cm; PADDING-LEFT: 2.85pt; PADDING-RIGHT: 2.85pt; BORDER-TOP: #-ece9d8; BORDER-RIGHT: windowtext 1pt solid; PADDING-TOP: 0cm" width="22%">
<p align="center"><span style="COLOR: black">N 18, </span></p>
<p align="center"><span style="COLOR: black">E 83.31</span></p></td></tr></tbody></table></div></div><div class="PUBLICATION_ORIGIN"><label id="s1089"></label><div name="-2995858" id="-2995858">(Oʻzbekiston Respublikasi qonun hujjatlari toʻplami, 2016-y., 26-son, 325-modda)</div></div></div>
                
            </div>
        </section>
        
    </div>
    
    <div style="display: none;">
<!-- START WWW.UZ TOP-RATING -->
<SCRIPT language="javascript" type="text/javascript">
		<!--
		top_js = "1.0"; top_r = "id=4079&r=" + escape(document.referrer) + "&pg=" + escape(window.location.href); document.cookie = "smart_top=1; path=/"; top_r += "&c=" + (document.cookie ? "Y" : "N")
		//-->
</SCRIPT>
<SCRIPT language="javascript1.1" type="text/javascript">
<!--
		top_js = "1.1"; top_r += "&j=" + (navigator.javaEnabled() ? "Y" : "N")
//-->
</SCRIPT>
<SCRIPT language="javascript1.2" type="text/javascript">
<!--
		top_js = "1.2"; top_r += "&wh=" + screen.width + 'x' + screen.height + "&px=" + (((navigator.appName.substring(0, 3) == "Mic")) ? screen.colorDepth : screen.pixelDepth)
//-->
</SCRIPT>
<SCRIPT language="javascript1.3" type="text/javascript">
<!--
		top_js = "1.3";
//-->
</SCRIPT>
<SCRIPT language="JavaScript" type="text/javascript">
		<!--
		top_rat = "&col=0C57A6&t=ffffff&p=DD7900"; top_r += "&js=" + top_js + ""; document.write('<a href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank"><img src="https://www.uz/plugins/top_rating/count/cnt.png?' + top_r + top_rat + '" width=88 height=31 border=0 alt="Топ рейтинг www.uz"></a>')//-->
</SCRIPT>
<NOSCRIPT>
		<A href="https://www.uz/rus/toprating/cmd/stat/id/4079" target="_blank">
				<img height="31" src="https://www.uz/plugins/top_rating/count/nojs_cnt.png?id=4079&pg=http%3A//lex.uz&col=0C57A6&t=ffffff&p=DD7900" width="88" border="0" alt="Топ рейтинг www.uz">
		</A>
</NOSCRIPT>
<!-- FINISH WWW.UZ TOP-RATING --></div>
</body>
</html>
<script> 
    function scrollText(hash) {
        location.href = "#" + hash;
        //$('html,body').animate({
        //    scrollTop: $(window).scrollTop() - 75
        //});
    }
</script>
<script>     
    //function scrollToElement(selector, time, verticalOffset) {
    //    time = typeof (time) != 'undefined' ? time : 1000;
    //    verticalOffset = typeof (verticalOffset) != 'undefined' ? verticalOffset : 0;
    //    element = $(selector);
    //    offset = element.offset();
    //    offsetTop = offset.top + verticalOffset;
    //    $('html, body').animate({
    //        scrollTop: offsetTop
    //    }, time);
    //}

    //jQuery.fn.extend({
    //    scrollToMe: function () {
    //        var x = jQuery(this).offset().top - 100;
    //        jQuery('html,body').animate({ scrollTop: x }, 500);
    //    }
    //});

    //function opentInAct(id) {
    //    $("#" + id).scrollToMe();
    //}

    $(document).ready(function () {
        $("#theDefCssID TABLE TD").css('display', '');
    });
</script>
<style>
    #divCont > DIV {
        margin-left: -2px;
        margin-right: -2px;
        padding-left: 2px;
        padding-right: 2px;
    }

    TD.fTD {
        width: 22px;
    }

    .OFFICIAL_SOUR_TEXT {
        display: none;
    }

    /*.document_view_body*/ header {
        clear: both;
        float: left;
        height: 36px;
        width: 100%;
        background-color: #2263a9;
    }

        /*.document_view_body header .logo {
            float: left;
            padding: 0 12px;
        }*/

        /*.document_view_body header nav.main_menu {
            float: none;
        }*/

        /*nav.main_menu {
        float: left;
        padding-left: 22px;
        position: relative;
        z-index: 9;
    }*/

        /*nav.main_menu > div {
            float: left;
            height: 34px;
            margin-top: 1px;
            width: 21px;
        }*/

        /*.document_view_body header nav.main_menu > ul {
        float: none;
        font-family: helvatica;
        font-size: 11px;
    }*/

        /*nav.main_menu > ul {
        float: left;
        font-size: 16px;
    }*/

        /*nav ul, nav ol {
        list-style: none outside none;
        margin: 0;
        padding: 0;
    }*/

        /*ul, ol {
        margin: 1em 0;
        padding: 0 0 0 40px;
    }*/


        /*.document_view_body header .logo a {
        display: block;
        width: 100%;
    }*/


        /*.document_view_body*/ header .logo a span {
            background: url("/images/bg/doc_v_logo.png") no-repeat scroll center center transparent;
            display: block;
            height: 36px;
            width: 85px;
        }

    /*.hover-popup {
        display: none;
        border: 1px solid #969696;
        border-radius: 5px;
        -moz-border-radius: 5px;
        -webkit-border-radius: 5px;
        -o-border-radius: 5px;
        -ms-border-radius: 5px;
        position: absolute;
        behavior: url(css/PIE.htc);
        box-shadow: 2px 2px 6px -2px #555;
        padding: 7px;
        background: #fdffde;
        bottom: 28px;
        left: 10px;
        max-width: 500px;
        text-overflow: ellipsis;
        white-space: nowrap;
        color: #000;
        overflow: hidden;
    }*/

    /*.pre-loader {
        text-align: center;
        width: 100%;
        padding-bottom: 0 !important;
    }*/

    /*.actondate {
        width: 385px;
        height: 46px;
        background-color: White;
        z-index: 2000;
        font-family: Arial;
        font-size: 14px;
        font-weight: bold;
        opacity: 0.7;
        padding-top: 10px;
        text-align: center;
        top: 37px;
    }*/
</style>
